Internal Iliac Artery Ligation and Abnormally Invasive Placenta

Placenta Percreta Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02728232
• Other study ID #: PP2302019
• Status: Completed
• Phase: N/A
• First received: March 31, 2016
• Last updated: April 14, 2017
• Start date: April 2016
• Est. completion date: April 1, 2017

Study information

• Verified date: April 2017
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This trial is set to detect the impact of bilateral internal iliac artery ligation on the amount of intra-operative blood loss during the hysterectomy procedure done for the management of abnormally invasive placenta

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: April 1, 2017
• Est. primary completion date: April 1, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 20 Years to 45 Years

Eligibility

Inclusion Criteria:

• females with pre-operative diagnosis of abnormally invasive placenta

Exclusion Criteria:

• refusal to get enrolled in the study

Related Conditions & MeSH terms

• Placenta Accreta
• Placenta Percreta

Intervention

Procedure:
• internal iliac artery ligation

• Cesarean Hysterectomy

Locations

Country	Name	City	State
Egypt	Kasr el aini hospital	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	amount of intra-operative hemorrhage		2-3 hours